Delivery Order SPE2DB20D1100-SPE2DB24FC6H0

Award Date 7/8/24
Potential Completion Date 7/9/24
Potential Value $5.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FC6H0
    Delivery Order

This federal contract award is for the delivery of the pharmaceutical product Wegovy 0.25 mg/0.5 ml pen 0.5ml to the Defense Logistics Agency (DLA). The contract, valued at $5,485.40, was awarded to AmerisourceBergen Drug Corp's Corporate Office Division, a major supplier of pharmaceuticals and medical supplies to the U.S. government.

This is a delivery order contract with a firm-fixed price pricing type. The contract has an ultimate completion date of July 9, 2024 and was awarded on July 8, 2024. The contract does not have a set-aside designation.

AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for AmerisourceBergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide.

Generated 10/7/24, 10:59 AM